Whole-body organ-level and kidney micro-dosimetric evaluations of 64Cu-loaded HER2/ErbB2-targeted liposomal doxorubicin (64Cu-MM-302) in rodents and primates
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Whole-body organ-level and kidney micro-dosimetric evaluations of 64Cu-loaded HER2/ErbB2-targeted liposomal doxorubicin (64Cu-MM-302) in rodents and primates
Authors
Keywords
Dosimetry, Copper-64, Positron emission tomography, Nanotherapeutics
Journal
EJNMMI Research
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-04-14
DOI
10.1186/s13550-015-0096-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A gradient-loadable 64Cu-chelator for quantifying tumor deposition kinetics of nanoliposomal therapeutics by positron emission tomography
- (2015) Helen Lee et al. Nanomedicine-Nanotechnology Biology and Medicine
- High liposomal doxorubicin tumour tissue distribution, as determined by radiopharmaceutical labelling with 99mTc-LD, is associated with the response and survival of patients with unresectable pleural mesothelioma treated with a combination of liposomal doxorubicin and cisplatin
- (2014) Oscar Arrieta et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Impact of Tumor HER2/ERBB2 Expression Level on HER2-Targeted Liposomal Doxorubicin-Mediated Drug Delivery: Multiple Low-Affinity Interactions Lead to a Threshold Effect
- (2013) B. S. Hendriks et al. MOLECULAR CANCER THERAPEUTICS
- Dosimetric evaluation of nanotargeted 188Re-liposome with the MIRDOSE3 and OLINDA/EXM programs
- (2012) Chih-Hsien Chang et al. ANNALS OF NUCLEAR MEDICINE
- HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity
- (2012) Joseph G. Reynolds et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- 64Cu loaded liposomes as positron emission tomography imaging agents
- (2011) Anncatrine L. Petersen et al. BIOMATERIALS
- Chemoradionuclide Therapy with 186Re-Labeled Liposomal Doxorubicin: Toxicity, Dosimetry, and Therapeutic Response
- (2011) Anuradha Soundararajan et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- APN/CD13-targeting as a strategy to alter the tumor accumulation of liposomes
- (2011) Michael Dunne et al. JOURNAL OF CONTROLLED RELEASE
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects
- (2010) Hiroshi Maeda BIOCONJUGATE CHEMISTRY
- Imaging Nanoprobe for Prediction of Outcome of Nanoparticle Chemotherapy by Using Mammography
- (2009) Efstathios Karathanasis et al. RADIOLOGY
- Comparative Dosimetric Evaluation of Nanotargeted 188Re-(DXR)-Liposome for Internal Radiotherapy
- (2008) Chih-Hsien Chang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats
- (2008) Michelle Longmire et al. Nanomedicine
- Preclinical Manufacture of Anti-HER2 Liposome-Inserting, scFv-PEG-Lipid Conjugate. 2. Conjugate Micelle Identity, Purity, Stability, and Potency Analysis
- (2005) David F. Nellis et al. BIOTECHNOLOGY PROGRESS
- Preclinical Manufacture of an Anti-HER2 scFv-PEG-DSPE, Liposome-Inserting Conjugate. 1. Gram-Scale Production and Purification
- (2005) David F. Nellis et al. BIOTECHNOLOGY PROGRESS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now